Hence, MCH receptor agonists may be useful in treating weight loss in ALS patients, which is particularly relevant considering that drugs known to increase food intake through the POMC/AgrP pathway were inefficient in increasing weight in ALS patients [73]. The gene discussed is AGRP; the disease is amyotrophic lateral sclerosis.